These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

395 related articles for article (PubMed ID: 30983433)

  • 61. Integrated genomic analysis identifies clinically relevant subtypes of renal clear cell carcinoma.
    Wu P; Liu JL; Pei SM; Wu CP; Yang K; Wang SP; Wu S
    BMC Cancer; 2018 Mar; 18(1):287. PubMed ID: 29534679
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Urine metabolomic analysis identifies potential biomarkers and pathogenic pathways in kidney cancer.
    Kim K; Taylor SL; Ganti S; Guo L; Osier MV; Weiss RH
    OMICS; 2011 May; 15(5):293-303. PubMed ID: 21348635
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Metabolomics of papillary thyroid carcinoma tissues: potential biomarkers for diagnosis and promising targets for therapy.
    Shang X; Zhong X; Tian X
    Tumour Biol; 2016 Aug; 37(8):11163-75. PubMed ID: 26935059
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Loss of SETD2 Induces a Metabolic Switch in Renal Cell Carcinoma Cell Lines toward Enhanced Oxidative Phosphorylation.
    Liu J; Hanavan PD; Kras K; Ruiz YW; Castle EP; Lake DF; Chen X; O'Brien D; Luo H; Robertson KD; Gu H; Ho TH
    J Proteome Res; 2019 Jan; 18(1):331-340. PubMed ID: 30406665
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Lysophosphatidylcholine acyltransferase 1 upregulation and concomitant phospholipid alterations in clear cell renal cell carcinoma.
    Du Y; Wang Q; Zhang X; Wang X; Qin C; Sheng Z; Yin H; Jiang C; Li J; Xu T
    J Exp Clin Cancer Res; 2017 May; 36(1):66. PubMed ID: 28494778
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Clinical utility of microRNAs in renal cell carcinoma: current evidence and future perspectives.
    Tsiakanikas P; Giaginis C; Kontos CK; Scorilas A
    Expert Rev Mol Diagn; 2018 Nov; 18(11):981-991. PubMed ID: 30345829
    [TBL] [Abstract][Full Text] [Related]  

  • 67. The metabolomic signature of hematologic malignancies.
    Allegra A; Innao V; Gerace D; Bianco O; Musolino C
    Leuk Res; 2016 Oct; 49():22-35. PubMed ID: 27526405
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Expression of miRNA-21 and miRNA-221 in clear cell renal cell carcinoma (ccRCC) and their possible role in the development of ccRCC.
    Szabó Z; Szegedi K; Gombos K; Mahua C; Flaskó T; Harda K; Halmos G
    Urol Oncol; 2016 Dec; 34(12):533.e21-533.e27. PubMed ID: 27427222
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Personalized discovery of altered pathways in clear cell renal cell carcinoma using accumulated normal sample data.
    Wang X; Ding M; Yang Y; Feng Y; Shi Z; Qiu F; Zhu M
    J BUON; 2016; 21(2):390-8. PubMed ID: 27273949
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Genomic and proteomic approaches to renal cell carcinoma.
    Zacchia M; Vilasi A; Capasso A; Morelli F; De Vita F; Capasso G
    J Nephrol; 2011; 24(2):155-64. PubMed ID: 20437403
    [TBL] [Abstract][Full Text] [Related]  

  • 71. HAVCR/KIM-1 activates the IL-6/STAT-3 pathway in clear cell renal cell carcinoma and determines tumor progression and patient outcome.
    Cuadros T; Trilla E; Sarró E; Vilà MR; Vilardell J; de Torres I; Salcedo M; López-Hellin J; Sánchez A; Ramón y Cajal S; Itarte E; Morote J; Meseguer A
    Cancer Res; 2014 Mar; 74(5):1416-28. PubMed ID: 24390735
    [TBL] [Abstract][Full Text] [Related]  

  • 72. MUC1 Tissue Expression and Its Soluble Form CA15-3 Identify a Clear Cell Renal Cell Carcinoma with Distinct Metabolic Profile and Poor Clinical Outcome.
    Lucarelli G; Rutigliano M; Loizzo D; di Meo NA; Lasorsa F; Mastropasqua M; Maiorano E; Bizzoca C; Vincenti L; Battaglia M; Ditonno P
    Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430448
    [TBL] [Abstract][Full Text] [Related]  

  • 73. DNA methylation of CRB3 is a prognostic biomarker in clear cell renal cell carcinoma.
    Li P; Liu J; Li J; Liu P
    Mol Biol Rep; 2019 Aug; 46(4):4377-4383. PubMed ID: 31147860
    [TBL] [Abstract][Full Text] [Related]  

  • 74. c-Myc modulates glucose metabolism via regulation of miR-184/PKM2 pathway in clear-cell renal cell carcinoma.
    Huang J; Kong W; Zhang J; Chen Y; Xue W; Liu D; Huang Y
    Int J Oncol; 2016 Oct; 49(4):1569-75. PubMed ID: 27431728
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Hepatitis A virus cellular receptor 1/kidney injury molecule-1 is a susceptibility gene for clear cell renal cell carcinoma and hepatitis A virus cellular receptor/kidney injury molecule-1 ectodomain shedding a predictive biomarker of tumour progression.
    Cuadros T; Trilla E; Vilà MR; de Torres I; Vilardell J; Messaoud NB; Salcedo M; Sarró E; López-Hellin J; Blanco A; Mir C; Ramón y Cajal S; Itarte E; Morote J; Meseguer A
    Eur J Cancer; 2013 May; 49(8):2034-47. PubMed ID: 23352434
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Aberrant Metabolism in Hepatocellular Carcinoma Provides Diagnostic and Therapeutic Opportunities.
    De Matteis S; Ragusa A; Marisi G; De Domenico S; Casadei Gardini A; Bonafè M; Giudetti AM
    Oxid Med Cell Longev; 2018; 2018():7512159. PubMed ID: 30524660
    [TBL] [Abstract][Full Text] [Related]  

  • 77. MicroRNAs in Serum Exosomes as Potential Biomarkers in Clear-cell Renal Cell Carcinoma.
    Zhang W; Ni M; Su Y; Wang H; Zhu S; Zhao A; Li G
    Eur Urol Focus; 2018 Apr; 4(3):412-419. PubMed ID: 28753793
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Long noncoding RNA MRCCAT1 promotes metastasis of clear cell renal cell carcinoma via inhibiting NPR3 and activating p38-MAPK signaling.
    Li JK; Chen C; Liu JY; Shi JZ; Liu SP; Liu B; Wu DS; Fang ZY; Bao Y; Jiang MM; Yuan JH; Qu L; Wang LH
    Mol Cancer; 2017 Jun; 16(1):111. PubMed ID: 28659173
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Frequent epigenetic suppression of tumor suppressor gene glutathione peroxidase 3 by promoter hypermethylation and its clinical implication in clear cell renal cell carcinoma.
    Liu Q; Jin J; Ying J; Sun M; Cui Y; Zhang L; Xu B; Fan Y; Zhang Q
    Int J Mol Sci; 2015 May; 16(5):10636-49. PubMed ID: 25970749
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Predictive biomarkers in renal cell cancer: insights in drug resistance mechanisms.
    van der Mijn JC; Mier JW; Broxterman HJ; Verheul HM
    Drug Resist Updat; 2014; 17(4-6):77-88. PubMed ID: 25457974
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.